The validity and utility of the M. D. Anderson symptom inventory in patients with breast cancer: Evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group

Clinical Breast Cancer

Volumn 13, Issue 5, 2013, Pages 325-334

  Mendoza, Tito R ^a   Zhao, Fengmin ^b   Cleeland, Charles S ^a   Wagner, Lynne I ^c   Patrick Miller, Linda J ^d   Fisch, Michael J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Eastern Cooperative Oncology Group; M. D. Anderson Symptom Inventory; Patient reported outcome; Symptom assessment; Validation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MD ANDERSON SYMPTOM INVENTORY; MULTICENTER STUDY (TOPIC); NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SECONDARY ANALYSIS; SELF REPORT; SENSITIVITY ANALYSIS; SYMPTOM ASSESSMENT; TEST RETEST RELIABILITY; VALIDATION STUDY; VALIDITY;

EASTERN COOPERATIVE ONCOLOGY GROUP; M. D. ANDERSON SYMPTOM INVENTORY; PATIENT-REPORTED OUTCOME; SYMPTOM ASSESSMENT; VALIDATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHECKLIST; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROFESSIONAL PRACTICE; PROGNOSIS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84883805923     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.02.014     Document Type: Article

References (39)

1. C.S. Cleeland Symptom burden: multiple symptoms and their impact as patient-reported outcomes J Natl Cancer Inst Monogr 37 2007 16 21
2. E. Basch, A. Iasonos, and T. McDonough Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study Lancet Oncol 7 2006 903 909
3. M.A. Neben-Wittich, P.J. Atherton, and D.J. Schwartz Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4) Int J Radiat Oncol Biol Phys 81 2011 397 402
4. M. Feuerstein, G.L. Bruns, and C. Pollman Management of unexplained symptoms in survivors of cancer J Oncol Pract 6 2010 308 311
5. C.S. Cleeland, X.S. Wang, and Q. Shi Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial J Clin Oncol 29 2011 994 1000
6. C. Given, B. Given, and M. Rahbar Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy J Clin Oncol 22 2004 507 516
7. C.S. Cleeland, J.A. Sloan, and D. Cella Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force Cancer 119 2013 411 420
8. K. Hofsø, C. Miaskowski, and K. Bjordal Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy Cancer Nurs 35 2012 167 177
9. P.D. Williams, U. Piamjariyakul, and K. Ducey Cancer treatment, symptom monitoring, and self-care in adults: pilot study Cancer Nurs 29 2006 347 355
10. J.H. Park, S.H. Bae, and Y.S. Jung Quality of life and symptom experience in breast cancer survivors after participating in a psychoeducational support program: a pilot study Cancer Nurs 35 2012 E34 E41
11. D. Cella, S.R. Land, and C.H. Chang Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women Breast Cancer Res Treat 109 2008 515 526
12. P.A. Ganz, L. Kwan, and A.L. Stanton Physical and psychosocial recovery in the year after primary treatment of breast cancer J Clin Oncol 29 2011 1101 1109
13. L. Terhorst, H. Blair-Belansky, and P.J. Moore Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy Psychooncology 20 2011 961 968
14. M.J. Brady, D.F. Cella, and F. Mo Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument J Clin Oncol 15 1997 974 986
15. M.A. Sprangers, M. Groenvold, and J.I. Arraras The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study J Clin Oncol 14 1996 2756 2768
16. A.L. Stanton, C.A. Bernaards, and P.A. Ganz The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer J Natl Cancer Inst 97 2005 448 456
17. K.J. Yost, S.E. Yount, and D.T. Eton Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) Breast Cancer Res Treat 90 2005 295 298
18. Symptom Management and Quality of Life Steering Committee. Clinical trials meeting on building bridges: the identification of core symptoms and health-related quality of life domains for use in cancer research. Available at: http://transformingtrials.cancer.gov/files/SxQOLSCPROCTPMExecutive%20Summary- FINAL.pdf. Accessed: August 7, 2012.
19. C.S. Cleeland, T.R. Mendoza, and X.S. Wang Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory Cancer 89 2000 1634 1646
20. J. Kirkova, M.P. Davis, and D. Walsh Cancer symptom assessment instruments: a systematic review J Clin Oncol 24 2006 1459 1473
21. Cleeland CS. The M. D. Anderson Symptom Inventory user guide [draft]. Available at: http://www.mdanderson.org/education-and-research/departments- programs-and-labs/departments-and-divisions/symptom-research/ symptom-assessment-tools/MDASI-userguide.pdf. Accessed September 12, 2012.
22. R.C. Serlin, T.R. Mendoza, and Y. Nakamura When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function Pain 61 1995 277 284
23. T.R. Mendoza, X.S. Wang, and C.S. Cleeland The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory Cancer 85 1999 1186 1196
24. J.C. Nunnally, and I.H. Bernstein Psychometric Theory 3rd ed. 1994 McGraw-Hill New York
25. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
26. J.A. Sloan, D. Vargas-Chanes, and C.C. Kamath Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in qualty-of-life measures J Cancer Integr Med 1 2003 41 47
27. J.A. Sloan, D. Cella, and R.D. Hays Clinical significance of patient-reported questionnaire data: another step toward consensus J Clin Epidemiol 58 2005 1217 1219
28. C.E. Metz Basic principles of ROC analysis Semin Nucl Med 8 1978 283 298
29. T.R. Mendoza, X.S. Wang, and C. Lu Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory Oncologist 16 2011 217 227
30. T.S. Armstrong, T. Mendoza, and I. Gning Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) J Neurooncol 80 2006 27 35
31. A. Fadol, T. Mendoza, and I. Gning Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure J Card Fail 14 2008 497 507
32. Shi Q, Giordano SH, Lu H, et al. Longitudinal change of pain and other symptoms in breast cancer patients with anastrozole treatment [abstract]. 33rd Annual San Antonio Breast Cancer Symposium, San Antonio TX, December 8-12, 2010. Abstract PD08-05.
33. E. Basch, D. Artz, and D. Dulko Patient online self-reporting of toxicity symptoms during chemotherapy J Clin Oncol 23 2005 3552 3561
34. D.L. Berry Patient-reported symptoms and quality of life integrated into clinical cancer care Semin Oncol Nurs 27 2011 203 210
35. E. Bruera Routine symptom assessment: good for practice and good for business Support Care Cancer 16 2008 537 538
36. D.W. Bruner, C.J. Bryan, and N. Aaronson Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks J Clin Oncol 25 2007 5051 5057
37. P.A. Ganz, and C.C. Gotay Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions J Clin Oncol 25 2007 5063 5069
38. S.Y. Zafar, D.C. Currow, and N. Cherny Consensus-based standards for best supportive care in clinical trials in advanced cancer Lancet Oncol 13 2012 e77 e82
39. X.S. Wang, C.S. Cleeland, and T.R. Mendoza Impact of cultural and linguistic factors on symptom reporting by patients with cancer J Natl Cancer Inst 102 2010 732 738